Bloomberg TV: Sir Andrew Witty, CEO, GSK, discusses antibiotic resistance in Davos

Related tags: Business Strategy

Andrew Witty, former CEO of GSK, discusses antibiotic effectiveness, the issues surrounding drug pricing and corporate inversions. He speaks to Bloomberg's Jonathan Ferro and Hans Nichols on "Countdown" from the World Economic Forum in Davos, Switzerland, January 2016.